In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1035794). This variant has not been reported in the literature in individuals affected with RET-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 10 of the RET protein (p.Gly10Glu).
ClinVar Genomic variation as it relates to human health
NM_020975.6(RET):c.29G>A (p.Gly10Glu)
Germline
Classification
Help
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
(3)
Help
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance
3
criteria provided, multiple submitters, no conflicts
Somatic
No data submitted for somatic clinical impact
Somatic
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_020975.6(RET):c.29G>A (p.Gly10Glu)
Variation ID: 1035794 Accession: VCV001035794.11
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 10q11.21 10: 43077287 (GRCh38) [ NCBI UCSC ] 10: 43572735 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 22, 2021 May 1, 2024 Nov 2, 2023 - HGVS
-
... more HGVS ... less HGVSNucleotide Protein Molecular
consequenceNM_020975.6:c.29G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_066124.1:p.Gly10Glu missense NM_000323.2:c.29G>A NP_000314.1:p.Gly10Glu missense NM_001406743.1:c.29G>A NP_001393672.1:p.Gly10Glu missense NM_001406744.1:c.29G>A NP_001393673.1:p.Gly10Glu missense NM_001406759.1:c.29G>A NP_001393688.1:p.Gly10Glu missense NM_001406760.1:c.29G>A NP_001393689.1:p.Gly10Glu missense NM_001406761.1:c.29G>A NP_001393690.1:p.Gly10Glu missense NM_001406762.1:c.29G>A NP_001393691.1:p.Gly10Glu missense NM_001406763.1:c.29G>A NP_001393692.1:p.Gly10Glu missense NM_001406764.1:c.29G>A NP_001393693.1:p.Gly10Glu missense NM_001406765.1:c.29G>A NP_001393694.1:p.Gly10Glu missense NM_001406766.1:c.29G>A NP_001393695.1:p.Gly10Glu missense NM_001406767.1:c.29G>A NP_001393696.1:p.Gly10Glu missense NM_001406768.1:c.29G>A NP_001393697.1:p.Gly10Glu missense NM_001406769.1:c.29G>A NP_001393698.1:p.Gly10Glu missense NM_001406770.1:c.29G>A NP_001393699.1:p.Gly10Glu missense NM_001406771.1:c.29G>A NP_001393700.1:p.Gly10Glu missense NM_001406772.1:c.29G>A NP_001393701.1:p.Gly10Glu missense NM_001406773.1:c.29G>A NP_001393702.1:p.Gly10Glu missense NM_001406774.1:c.29G>A NP_001393703.1:p.Gly10Glu missense NM_001406775.1:c.29G>A NP_001393704.1:p.Gly10Glu missense NM_001406776.1:c.29G>A NP_001393705.1:p.Gly10Glu missense NM_001406777.1:c.29G>A NP_001393706.1:p.Gly10Glu missense NM_001406778.1:c.29G>A NP_001393707.1:p.Gly10Glu missense NM_001406779.1:c.29G>A NP_001393708.1:p.Gly10Glu missense NM_001406780.1:c.29G>A NP_001393709.1:p.Gly10Glu missense NM_001406781.1:c.29G>A NP_001393710.1:p.Gly10Glu missense NM_001406782.1:c.29G>A NP_001393711.1:p.Gly10Glu missense NM_001406783.1:c.29G>A NP_001393712.1:p.Gly10Glu missense NM_001406784.1:c.29G>A NP_001393713.1:p.Gly10Glu missense NM_001406785.1:c.29G>A NP_001393714.1:p.Gly10Glu missense NM_001406786.1:c.29G>A NP_001393715.1:p.Gly10Glu missense NM_001406787.1:c.29G>A NP_001393716.1:p.Gly10Glu missense NM_001406788.1:c.29G>A NP_001393717.1:p.Gly10Glu missense NM_001406789.1:c.29G>A NP_001393718.1:p.Gly10Glu missense NM_001406790.1:c.29G>A NP_001393719.1:p.Gly10Glu missense NM_001406791.1:c.29G>A NP_001393720.1:p.Gly10Glu missense NM_001406792.1:c.29G>A NP_001393721.1:p.Gly10Glu missense NM_001406793.1:c.29G>A NP_001393722.1:p.Gly10Glu missense NM_001406794.1:c.29G>A NP_001393723.1:p.Gly10Glu missense NM_020629.2:c.29G>A NP_065680.1:p.Gly10Glu missense NM_020630.7:c.29G>A NP_065681.1:p.Gly10Glu missense NC_000010.11:g.43077287G>A NC_000010.10:g.43572735G>A NG_007489.1:g.5219G>A NG_045003.1:g.4474G>A LRG_518:g.5219G>A LRG_518t1:c.29G>A LRG_518p1:p.Gly10Glu LRG_518t2:c.29G>A LRG_518p2:p.Gly10Glu - Protein change
- G10E
- Other names
- -
- Canonical SPDI
- NC_000010.11:43077286:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
| Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
|---|---|---|---|---|---|---|
| HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
| RET | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
3598 | 3720 | |
| LOC106736614 | - | - | - | GRCh38 | - | 75 |
Conditions - Germline
| Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
|---|---|---|---|---|
| Uncertain significance (2) |
criteria provided, multiple submitters, no conflicts
|
Nov 2, 2023 | RCV001338708.11 | |
| Uncertain significance (1) |
criteria provided, single submitter
|
Aug 24, 2023 | RCV002438769.3 |
Submissions - Germline
| Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
|---|---|---|---|---|---|
|
Uncertain significance
(May 10, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Multiple endocrine neoplasia, type 2
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001532394.4
First in ClinVar: Mar 22, 2021 Last updated: Feb 28, 2024 |
Comment:
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant … (more)
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1035794). This variant has not been reported in the literature in individuals affected with RET-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 10 of the RET protein (p.Gly10Glu). (less)
|
|
|
Uncertain Significance
(Nov 02, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Multiple endocrine neoplasia, type 2
(Autosomal dominant inheritance)
Affected status: unknown
Allele origin:
germline
|
All of Us Research Program, National Institutes of Health
Accession: SCV004840059.1
First in ClinVar: Apr 20, 2024 Last updated: Apr 20, 2024
Comment:
This study involves interpretation of variants in research participants for the purpose of population health screening. Participant phenotype was not available at the time of … (more)
This study involves interpretation of variants in research participants for the purpose of population health screening. Participant phenotype was not available at the time of variant classification. Additional details can be found in publication PMID: 35346344, PMCID: PMC8962531 (less)
|
Comment:
This missense variant replaces glycine with glutamic acid at codon 10 of the RET protein. Computational prediction suggests that this variant may not impact protein … (more)
This missense variant replaces glycine with glutamic acid at codon 10 of the RET protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with RET-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. (less)
Number of individuals with the variant: 1
|
|
|
Uncertain significance
(Aug 24, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002750749.3
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
The p.G10E variant (also known as c.29G>A), located in coding exon 1 of the RET gene, results from a G to A substitution at nucleotide … (more)
The p.G10E variant (also known as c.29G>A), located in coding exon 1 of the RET gene, results from a G to A substitution at nucleotide position 29. The glycine at codon 10 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. (less)
|
Comment:
Comment:
This missense variant replaces glycine with glutamic acid at codon 10 of the RET protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with RET-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Comment:
The p.G10E variant (also known as c.29G>A), located in coding exon 1 of the RET gene, results from a G to A substitution at nucleotide position 29. The glycine at codon 10 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Germline Functional Evidence
| There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Comment:
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1035794). This variant has not been reported in the literature in individuals affected with RET-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 10 of the RET protein (p.Gly10Glu).
Comment:
This missense variant replaces glycine with glutamic acid at codon 10 of the RET protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with RET-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Comment:
The p.G10E variant (also known as c.29G>A), located in coding exon 1 of the RET gene, results from a G to A substitution at nucleotide position 29. The glycine at codon 10 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Citations for germline classification of this variant
Help| There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for rs1303812507 ...
HelpThese citations are identified by LitVar using
the rs number, so they may include citations for more than one variant
at this location. Please review the LitVar results carefully for your
variant of interest.
Record last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.